For the first time ever, scientists are attempting to reverse cellular aging in a living patient. The target: incurable vision loss. The risk: cancer.

The remodelling of the human brain's immune environment by the tuberculosis vaccine BCG could offer a potential biological ...

Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

A groundbreaking human trial of ER-100, a cellular reprogramming therapy, has begun, testing whether damaged eye cells can be rejuvenated and potentially opening a new chapter in the science of aging.

Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn't moved past 115 years.

When Dolly the sheep—the first cloned mammal—was born 30 years ago, she became one of the most famous animals in science ...

Microplastics are abundant in municipal wastewater, with concentrations ranging from 10 to 470 particles per liter in sewage. Despite the vast scale of urban sewer systems—extensive underground ...

When Dolly the sheep – the first cloned mammal – was born 30 years ago, she became one of the most famous animals in science ...

Over the past several months, advancements in artificial intelligence (AI) have led some high-profile companies to attempt to ...

STEMCELL Technologies and the Centre for Commercialization of Regenerative Medicine (CCRM) today announced a partnership to expand access to high-quality human induced pluripotent stem cell (iPSC) ...